Clinical Trial Update: Use Of SB-705498 In The Acute Treatment Of Migraine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SB-705498 for acute treatment of migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SB-705498

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine, Acute | Phase 2 | Status: COMPLETED